[Basic comments on the treatment of arrhythmias].
D000404:Ajmaline / Q000627:therapeutic use; D001145:Arrhythmias, Cardiac / Q000188:drug therapy*; D006327:Heart Block / Q000628:therapy; D006801:Humans; D006993:Hypnotics and Sedatives / Q000627:therapeutic use; D008012:Lidocaine / Q000627:therapeutic use; D010138:Pacemaker, Artificial; D011342:Procainamide / Q000627:therapeutic use; D011802:Quinidine / Q000627:therapeutic use; D013034:Sparteine / Q000627:therapeutic use; D014700:Verapamil / Q000627:therapeutic use
D006993:Hypnotics and Sedatives; D000404:Ajmaline; D013034:Sparteine; D008012:Lidocaine; D014700:Verapamil; D011802:Quinidine; D011342:Procainamide
Grundsätzliches zur Behandlung von Herzryhthmusstörungen